TITLE

New drugs and dosage forms

PUB. DATE
June 2011
SOURCE
American Journal of Health-System Pharmacy;6/1/2011, Vol. 68 Issue 11, p960
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
61141503

 

Related Articles

  • DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHODS FOR THE ESTIMATION OF IBUPROFEN AND FAMOTIDINE. WANI, YOGITA B.; PATIL, DIPAK D. // International Journal of Pharmacy & Pharmaceutical Sciences;Jul2013, Vol. 5 Issue 3, p358 

    Objective: Two simple, accurate, precise, reproducible and an economical spectrophotometric methods were developed for the simultaneous estimation of ibuprofen and famotidine in pharmaceutical bulk and synthetic mixture. Methods: The first method was developed on the basis of Q-absorbance ratio...

  • ACR Roundup.  // BioWorld Today;11/10/2010, Vol. 21 Issue 218, p2 

    This section offers news briefs on research findings presented at the American College of Rheumatology meeting in Atlanta, Georgia. ChemoCentix Inc. of Mountain View, California proved the drug safety of CCX354 for rheumatoid arthritis. A study on ibuprofen and high-dose famotidine formulation...

  • When methotrexate fails to control rheumatoid arthritis.  // BMJ: British Medical Journal;6/22/2013, Vol. 346 Issue 7913, p11 

    The article focuses on a study conducted to determine the effectiveness of additional sulfasalazine and hydroxychloroquine triple therapy after the effect of methotrexate fails in controlling rheumatoid arthritis in human beings.

  • Sulfasalazine, methotrexate + prednisolone worthwhile in RA.  // PharmacoEconomics & Outcomes News;11/6/2004, Issue 465, p4 

    Reports on the study of combination therapy in patients with rheumatoid arthritis in the Netherlands. Methodology of the study; Comparison on the costs for patients receiving combination therapy with those receiving sulfasalazine alone.

  • Pain relievers may increase bleeding;.  // Clinical Advisor;Oct2011, Vol. 14 Issue 10, p16 

    No abstract available.

  • Placebo-Controlled Study of the Analgesic Efficacy of a Paracetamol 500mg /Codeine 30mg Combination Together with Low-Dose vs High-Dose Diclofenac in Rheumatoid Arthritis. Glowinski, J.; Boccard, E. // Clinical Drug Investigation;1999, Vol. 18 Issue 3, p189 

    Objective: This double-blind randomised study was designed to compare paracetamol 500mg/codeine 30mg (PC) [3 times daily] plus diclofenac 50mg once a day with diclofenac 50mg twice a day (DI) over 7 days in two parallel groups of 30 patients with residual persisting pain despite adjusted basic...

  • Combination Therapy with Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis. Garrood, T.; Scott, D.L. // BioDrugs;2001, Vol. 15 Issue 8, p543 

    There is increasing interest in using combinations of two or more disease modifying anti-rheumatic drugs to treat rheumatoid arthritis. The use of such combinations is increasing in routine clinical practice. We have identified 18 well-conducted, randomised controlled trials of the use of...

  • The Efficacy of Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis in Local Patients of Karachi. Baig, M. S.; Humail, S. M.; Zaidi, S. I.; Noor, S.; Bano, S.; Rehman, S.; Fawwad, A. // Pakistan Journal of Biological Sciences;2009, Vol. 12 Issue 4, p339 

    The primary objective of the study is to assess the efficacy of the 'Disease Modifying Anti-Rheumatic Drugs (DMARDs) on the disease activity in Rheumatoid Arthritis (RA) in the local patients of Karachi. The secondary objective is to evaluate whether the combination of two concurrent DMARDs...

  • Therapeutic effects of the combination of methotrexate and bucillamine in early rheumatoid arthritis: a multicenter, double-blind, randomized controlled study. Ichikawa, Yoichi; Saito, Terunobu; Yamanaka, Hisashi; Akizuki, Masashi; Kondo, Hirobumi; Kobayashi, Shigeto; Oshima, Hisaji; Kawai, Shinichi; Hama, Nobuaki; Yamada, Hidehiro; Mimori, Tsuneyo; Amano, Koichi; Tanaka, Yasushi; Matsuoka, Yasuo; Yamamoto, Sumiki; Matsubara, Tsukasa; Murata, Norikazu; Asai, Tomiaki; Suzuki, Yasuo // Modern Rheumatology (Springer Science & Business Media B.V.);Oct2005, Vol. 15 Issue 5, p323 

    Disease-modifying antirheumatic drug (DMARD) combination therapies are used widely, but there have been few reports clearly demonstrating that combination therapy is more effective than DMARD monotherapy. We conducted a multicenter, double-blind controlled trial in order to clarify that the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics